Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001703849 | SCV000525269 | likely benign | not provided | 2021-05-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000526560 | SCV000623867 | benign | Hypertrophic cardiomyopathy | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618253 | SCV000740147 | likely benign | Cardiovascular phenotype | 2017-04-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330670 | SCV004038213 | benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing |